The Efficacy and Safety of Prolonged Oral Anticoagulation for the Prevention of Thromboembolic Events in Patients Recovered From COVID-19 1 Year After Hospital Discharge: The SARCOV-19 Prospective Registry

Our objective in this study is to know the predictors of thromboembolic events 1 year after hospitalization for severe COVID-19 and the benefit of preventive oral anticoagulation for 1 month to placebo after release. We conducted a prospective study to determine the benefit of preventive anticoagula...

Descripción completa

Detalles Bibliográficos
Autores principales: Aidouni, Ghizlane El, Bouchlarhem, Amine, Bkiyar, Houssam, Ismaili, Nabila, El Ouafi, Noha, Housni, Brahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
COVID-19 Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900156/
https://www.ncbi.nlm.nih.gov/pubmed/36721349
http://dx.doi.org/10.1177/10760296231151710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900156/
https://www.ncbi.nlm.nih.gov/pubmed/36721349
http://dx.doi.org/10.1177/10760296231151710

Ejemplares similares